UBS Global Wealth Management has cut its forecast for Chinese equities due to rising concerns over potential US tariffs and a ...
Asian equities were overall lower on a stronger U.S. dollar overnight, as Mainland China outperformed while Hong Kong and ...
AstraZeneca beat third-quarter expectations and lifted its guidance Tuesday, but AstraZeneca stock slipped amid a criminal probe in China.
Swiss money manager cuts mid-2025 and end-2025 targets for MSCI China Index because of tariff uncertainties and disappointing ...
The package, which was approved Friday, was designed to alleviate local government debt but fell short of investor expectations.
China’s latest debt swap plan disappointed stock investors, with market watchers now turning their focus to upcoming policy ...
It has limited-to-no sales in China. The AI-driven software company has several key qualities that make it positively stand ...